Description

ATP–MgCl? injection provides extracellular adenosine triphosphate complexed with magnesium, enabling rapid uptake by cells to restore intracellular energy stores. Its formula improves tissue oxygenation, stabilizes cell membranes, and assists microvascular flow in ischemic or shock conditions. Due to ATP’s short half-life, this fast-acting preparation is ideal for acute experimental interventions.

Product Specifications

Mechanism of Action

ATP–MgCl? delivers readily available ATP directly to cells, bypassing metabolic delays, while Mg²? aids in ATP activation and stabilizes cellular membranes. This combination improves microcirculation, energy support, and protects tissues in ischemic and shock models.

Research Application Areas

• Ischemia–reperfusion models (liver, heart, kidney)

• Hemorrhagic or septic shock experiments

• Microcirculation and organ perfusion studies

• Cellular energy and mitochondrial support research

• Mitochondrial injury and membrane stabilization assays

Preclinical studies show improved cardiac output, reduced pulmonary artery pressure, and enhanced survival in septic and shock models after ATP–MgCl? administration.

Safety & Handling

• Handling: Requires aseptic technique, lab PPE.

• Storage: Maintain between 2–8?°C; protect from light.

• Administration: Use promptly due to ATP’s short half-life; infuse slowly to monitor for hypotension.

• Precautions: Experimental use only; improper use may cause cardiovascular effects.

Core Keywords

ATP injection, ATP magnesium chloride injection, ATP–MgCl? 100mg, H20050737, ischemia model ATP, shock therapy research, organ perfusion ATP, laboratory ATP MgCl?

Research Use Disclaimer

This product is for laboratory and preclinical research only. Not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may pose legal or health risks. Use under approved institutional protocols.